Celleron Therapeutics announces MHRA Clinical Trial Authorisation for CXD101 in Microsatellite-Stable Colorectal Cancer
Download as a PDFOxford, UK, 26 March 2018 – Celleron Therapeutics, the UK-based company developing personalised medicine for cancer patients, has today announced that the UK MHRA has granted approval for the conduct of a clinical trial with its lead … Read More